Lunch symposium: How can mRNA science shape the future of public health?
Friday 11 November, 12:45 - 13:45 CET, Alpha 3
During this session, chaired by Ulf Dittmer, Professor of Experimental Virology at the University Hospital in Essen, Germany, the expert faculty will provide an overview of how mRNA science offers the potential to transform the future of public health.
Hamilton Bennett, Senior Director of Vaccine Access and Partnerships at Moderna will share the development journey of the mRNA-1273 COVID-19 vaccine and its role in pandemic response and preparedness. She will also provide an overview of the recent advancements from the global health portfolio, and Moderna’s approach to deploying the platform against emerging and neglected infectious diseases.
Pier Luigi Lopalco, Professor of Hygiene and Preventive Medicine at the University of Salento, Italy, will then explore the current landscape of unprecedented challenges that public health faces across important viral diseases, reflecting on vaccine development and hesitancy, as well as pediatric vaccination uptake. Professor Lopalco will also consider the impact of advances in vaccinology on other areas, including respiratory diseases such as RSV and influenza and new emergent infections.
The symposium will end with a Q&A session where attendees are invited to pose questions to the speakers in an opportunity to discuss further the potential of mRNA science.
12:45 - 12:55 Welcome and introduction
Chair: Professor Ulf Dittmer, University of Duisburg-Essen, Germany
12:55 - 13:10 mRNA platform and pandemic preparedness
Hamilton Bennett, Moderna, Inc
13:10 - 13:25 Beyond COVID-19: the next threat to public health
Professor Pier Luigi Lopalco, University of Salento, Italy
13:25 - 13:45 Discussion and Q&A
Click for the abstract/programme here.
Registration is not required. Delegates can attend the lunch symposium free of charge. Get your lunch in the Exhibiton / Catering Area and take it to the session room.